发明授权
- 专利标题： Modified exendins and exendin agonists
- 专利标题（中）： 改良的毒蜥外泌肽和毒蜥外泌激素
-
申请号： US11174089申请日： 2005-06-30
-
公开(公告)号： US08057822B2公开(公告)日： 2011-11-15
- 发明人: Kathryn S. Prickett , Andrew A. Young
- 申请人： Kathryn S. Prickett , Andrew A. Young
- 申请人地址： US CA San Diego
- 专利权人： Amylin Pharmaceuticals, Inc.
- 当前专利权人： Amylin Pharmaceuticals, Inc.
- 当前专利权人地址： US CA San Diego
- 代理机构： Connolly Bove Lodge & Hutz LLP
- 主分类号： A61K9/14
- IPC分类号： A61K9/14 ; A61K38/00
摘要：
Novel modified exendins and exendin agonists having an exendin or exendin agonist linked to one or more polyethylene glycol polymers, for example, and related formulations and dosages and methods of administration thereof are provided. These modified exendins and exendin agonists, compositions and methods are useful in treating diabetes and conditions that would be benefited by lowering plasma glucose or delaying and/or slowing gastric emptying or inhibiting food intake.
公开/授权文献
- US20050267034A1 Modified exendins and exendin agonists 公开/授权日：2005-12-01
信息查询
